🚀 VC round data is live in beta, check it out!
Envoy Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Envoy Medical and similar public comparables like Tobii, Elutia, Accuray, Svas Biosana and more.
Envoy Medical Overview
About Envoy Medical
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
Founded
1995
HQ
Employees
42
Website
Financials (LTM)
EV
$47M
Envoy Medical Financials
Envoy Medical reported last 12-month revenue of $230K.
In the same LTM period, Envoy Medical generated ($640K) in gross profit and had net loss of ($25M).
Revenue (LTM)
Envoy Medical P&L
In the most recent fiscal year, Envoy Medical reported revenue of $241K and EBITDA of ($22M).
Envoy Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $230K | XXX | $241K | XXX | XXX | XXX |
| Gross Profit | ($640K) | XXX | ($633K) | XXX | XXX | XXX |
| Gross Margin | (279%) | XXX | (263%) | XXX | XXX | XXX |
| EBITDA | — | XXX | ($22M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (9072%) | XXX | XXX | XXX |
| EBIT Margin | (9667%) | XXX | (9241%) | XXX | XXX | XXX |
| Net Profit | ($25M) | XXX | ($24M) | XXX | XXX | XXX |
| Net Margin | (10685%) | XXX | (9857%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Envoy Medical Stock Performance
Envoy Medical has current market cap of $50M, and enterprise value of $47M.
Market Cap Evolution
Envoy Medical's stock price is $0.65.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $47M | $50M | -0.9% | XXX | XXX | XXX | $-0.31 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEnvoy Medical Valuation Multiples
Envoy Medical trades at 206.7x EV/Revenue multiple, and (2.2x) EV/EBITDA.
EV / Revenue (LTM)
Envoy Medical Financial Valuation Multiples
As of April 11, 2026, Envoy Medical has market cap of $50M and EV of $47M.
Equity research analysts estimate Envoy Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Envoy Medical has a P/E ratio of (2.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $50M | XXX | $50M | XXX | XXX | XXX |
| EV (current) | $47M | XXX | $47M | XXX | XXX | XXX |
| EV/Revenue | 206.7x | XXX | 197.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (2.2x) | XXX | XXX | XXX |
| EV/EBIT | (2.1x) | XXX | (2.1x) | XXX | XXX | XXX |
| EV/Gross Profit | (74.2x) | XXX | (75.0x) | XXX | XXX | XXX |
| P/E | (2.0x) | XXX | (2.1x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (2.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Envoy Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Envoy Medical Margins & Growth Rates
Envoy Medical's revenue in the last 12 month declined by (13%).
Envoy Medical's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.5M for the same period.
Envoy Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (13%) | XXX | (17%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (9072%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 10% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 438% | XXX | 506% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3341% | XXX | 3291% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 5615% | XXX | 5181% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 8978% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Envoy Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Tobii | XXX | XXX | XXX | XXX | XXX | XXX |
| Elutia | XXX | XXX | XXX | XXX | XXX | XXX |
| Accuray | XXX | XXX | XXX | XXX | XXX | XXX |
| Svas Biosana | XXX | XXX | XXX | XXX | XXX | XXX |
| SMAIO | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Envoy Medical M&A Activity
Envoy Medical acquired XXX companies to date.
Last acquisition by Envoy Medical was on XXXXXXXX, XXXXX. Envoy Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Envoy Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEnvoy Medical Investment Activity
Envoy Medical invested in XXX companies to date.
Envoy Medical made its latest investment on XXXXXXXX, XXXXX. Envoy Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Envoy Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Envoy Medical
| When was Envoy Medical founded? | Envoy Medical was founded in 1995. |
| Where is Envoy Medical headquartered? | Envoy Medical is headquartered in United States. |
| How many employees does Envoy Medical have? | As of today, Envoy Medical has over 42 employees. |
| Who is the CEO of Envoy Medical? | Envoy Medical's CEO is Brent T. Lucas. |
| Is Envoy Medical publicly listed? | Yes, Envoy Medical is a public company listed on Nasdaq. |
| What is the stock symbol of Envoy Medical? | Envoy Medical trades under COCH ticker. |
| When did Envoy Medical go public? | Envoy Medical went public in 2023. |
| Who are competitors of Envoy Medical? | Envoy Medical main competitors are Tobii, Elutia, Accuray, Svas Biosana. |
| What is the current market cap of Envoy Medical? | Envoy Medical's current market cap is $50M. |
| What is the current revenue of Envoy Medical? | Envoy Medical's last 12 months revenue is $230K. |
| What is the current revenue growth of Envoy Medical? | Envoy Medical revenue growth (NTM/LTM) is (13%). |
| What is the current EV/Revenue multiple of Envoy Medical? | Current revenue multiple of Envoy Medical is 206.7x. |
| Is Envoy Medical profitable? | No, Envoy Medical is not profitable. |
| What is the current net income of Envoy Medical? | Envoy Medical's last 12 months net income is ($25M). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.